All comparisons

Compounded tirzepatide vs Zepbound: price, differences and how to buy

By PacificRx editorial team · Prices checked

The short answer

Zepbound is Eli Lilly's FDA-approved tirzepatide for chronic weight management, sold self-pay on LillyDirect from $299/month for the 2.5 mg dose and $449/month for 7.5–15 mg with on-time refills. Compounded tirzepatide at PacificRx starts at $149/month plus a $30/month doctor & care-team fee after an online clinician review. It contains the same active ingredient but is not FDA-approved and is not the branded product.

Buy tirzepatide online

Side by side

What it isPacificRx:Compounded tirzepatide made by a licensed U.S. pharmacy for youZepbound:Branded tirzepatide by Eli Lilly, FDA-approved for chronic weight management and obstructive sleep apnea with obesity
Starting dose pricePacificRx:$149/month + a $30/month doctor & care-team fee ($179/month total)Zepbound:$299/month for 2.5 mg (LillyDirect self-pay, vial or pen)
Higher dosesPacificRx:Up to $399/month, by dose tierZepbound:$399/month for 5 mg; $449/month for 7.5–15 mg with refills within 45 days (otherwise $499–$699)
Prescription neededPacificRx:Yes, from an online clinician reviewZepbound:Yes
InsurancePacificRx:Not used (self-pay)Zepbound:Self-pay vials are cash-only; some plans cover pens
FDA reviewPacificRx:Not FDA-approved (compounded)Zepbound:FDA-approved

Third-party prices are from the sources below as of 2026-11-15 and can change; confirm them at the source. PacificRx prices are read from the current catalog.

Same active ingredient, different products

Both contain tirzepatide, a once-weekly GIP and GLP-1 receptor agonist. Zepbound is a manufactured, FDA-approved product with a label, a dosing schedule studied in clinical trials, and FDA oversight of manufacturing.

PacificRx prescribes compounded preparations made by licensed U.S. pharmacies for an individual patient. A compounded preparation is not the branded product, is not an FDA-approved generic, and has not been reviewed by the FDA for safety, effectiveness or quality. A clinician decides whether it is appropriate for you.

What you pay

On LillyDirect, Zepbound's self-pay price is set by dose: $299/month for 2.5 mg, $399/month for 5 mg, and $449/month for 7.5 mg through 15 mg when refills are on time. You also need a prescription, which may come with its own visit fee.

At PacificRx the starting dose is $149/month for the medication plus a $30/month doctor & care-team fee, and the clinician visit and follow-up are covered by that fee. Higher dose tiers cost more, up to $399/month for the medication. Every tier is listed on the tirzepatide page before you start.

Which one is right for you

If your insurance covers Zepbound, or you want the FDA-approved product, Zepbound is the straightforward choice. If you are paying yourself and a clinician agrees a compounded preparation is clinically appropriate for you, compounded tirzepatide costs less. A licensed clinician makes that call during your review.

How buying tirzepatide online works at PacificRx

You complete a medical intake online, see the plan price before checkout, and authorize your card. The card is captured only if a licensed clinician approves a prescription; otherwise the hold is released. Medication ships free from a licensed U.S. pharmacy, and no insurance is needed.

Questions

Is compounded tirzepatide the same as Zepbound?

No. It has the same active ingredient, but it is a different product made by a compounding pharmacy for an individual patient. It is not FDA-approved and is not interchangeable with Zepbound.

Is compounded tirzepatide cheaper than Zepbound?

At the starting dose, yes: PacificRx's starting-dose tirzepatide is $149/month plus a $30/month doctor & care-team fee, compared with $299/month for Zepbound 2.5 mg on LillyDirect, before any separate visit fee.

Can I buy tirzepatide online without a prescription?

No. Tirzepatide is prescription-only in every form. You can request one online: a licensed clinician reviews your intake and decides whether to prescribe.

Sources

More comparisons